Steeve Néron
Corporate Officer/Principal at TETRA BIO-PHARMA INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Guy Chamberland | M | - |
TALLC Corp., Inc.
 TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | 8 years |
| Damon C. Smith | M | - |
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | - |
| H. Norton | M | 63 | 4 years | |
| Sylvain Guénette | M | - |
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | - |
| Aurelia de Pauw | M | - |
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | 6 years |
| Natalie Leroux | F | - | - | |
| Mark A. Beaudet | M | - |
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | - |
| Catherine Auld | F | - | 3 years | |
| Dale MacCandlish-Weil | F | 68 | 4 years | |
| John Kim | M | - | 3 years | |
| Ofer Yifrach-Stav | M | - | 6 years | |
| Sonia Gervais | F | - |
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | - |
| Dania Scott | F | - | 4 years | |
| Derek Theriault | M | - | - | |
| Michael Olders | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Benoit Chotard | M | 59 | 1 years | |
| Gregory Drohan | M | - | 2 years | |
| Bill Cheliak | M | - | 4 years | |
| Carl Merton | M | - | 4 years | |
| Sabino di Paola | M | 46 | 5 years | |
| Jacques Dessureault | M | - |
Valeant Canada Ltd.
 Valeant Canada Ltd. Pharmaceuticals: MajorHealth Technology Valeant Canada Ltd. manufactures and distributes pharmaceutical products to both primary care and physicians in Canada. The firm focuses its efforts primarily in the areas of pain management, cardiovascular disease, neurology and dermatology. The company was founded in 1956 and is headquartered in Laval, Canada. | 5 years |
| Robert J. Bechard | M | - | 3 years | |
| Bernard Lapointe | M | - |
Université du Québec à Chicoutimi
| 1 years |
| Leslie Auld | F | - | - | |
| Mathieu Piché | M | 65 |
Université du Québec à Chicoutimi
| 1 years |
| Sylvain Chrétien | M | 59 | - | |
| Serge Verreault | M | - |
Valeant Canada Ltd.
Valeant Canada Ltd. Pharmaceuticals: MajorHealth Technology Valeant Canada Ltd. manufactures and distributes pharmaceutical products to both primary care and physicians in Canada. The firm focuses its efforts primarily in the areas of pain management, cardiovascular disease, neurology and dermatology. The company was founded in 1956 and is headquartered in Laval, Canada. | 7 years |
| Bernard Lessard | M | - | 2 years | |
| Jean Simon | M | 68 |
Université du Québec à Chicoutimi
| 4 years |
| Jean-Francois Boily | M | - | 1 years | |
| Graham Wood | M | - | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 31 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Steeve Néron
- Personal Network
